Search results
Allergy-immunology specialists Dang and Patel named 2024 Castle Connolly Top Doctors
Digital Journal· 1 day agoCOLUMBUS, OH, June 04, 2024 /24-7PressRelease/ -- Andrew T. Dang, MD, and Gital K. Patel, MD, have been recognized as 2024 Castle Connolly Top Doctors — the first year for ...
Want to Prevent Childhood Peanut Allergies? Then Feed Your Kids Peanut Butter, Study Says
People via Yahoo News· 7 days agoThis is a far cry from the 2000 recommendation from the American Academy of Pediatrics, which...
Discrimination and negligence at Seattle Children’s hospital led to teen’s death, family alleges in...
CNN via AOL· 5 days agoA 16-year-old in Bothell, Washington, suffered from a severe allergic reaction to medication for...
Some drugmakers to cap cost of asthma inhalers at $35 a month
NBC News via Yahoo News· 5 days agoStarting Saturday, the cost of inhalers will fall for many Americans, as new out-of-pocket price...
How Air Quality Affects Asthma
Time via AOL· 6 days ago“For many, it’s simply an annoyance, and they may not worry about it,” he adds. But for those with severe asthma, the impact can be much greater, Peden...
Q&A: Illuminating the mechanisms behind severe inflammation in asthma
Medical Xpress· 6 days agoJoshua A. Boyce, MD, chief of the Division of Allergy and Clinical Immunology at Brigham
Chinese cell therapy may treat asthma long term with a single jab: study
South China Morning Post· 3 days agoCytokines are signalling proteins that help control inflammation in the body, but too many cytokines...
Surprising find could lead to drugs for severe allergic reactions
Futurity· 1 day agoWhen mast cells, which reside under the skin, around blood vessels and in the linings of the airways...
Jasper Therapeutics to Present Data on Briquilimab in Mast Cell Driven Diseases at the EAACI...
Benzinga· 6 days agoREDWOOD CITY, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (NASDAQ:JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel antibody therapy targeting